Recent studies have used CD63 and TSG101 as markers toidentify and characterize EVs in patients with lung cancer(18), uveal melanoma(14), chronic Chagas disease(19) and cerebraltoxoplasmosis(20). Here, CD63 is linked to lung cancer.